Risk of Recurrent Hypoglycemia and Long-term Survival after total Pancreatectomy
Advancements in insulins and CGMs provide acceptable outcomes after TP without supplemental islet transplantation, and lower risk of SHE than previously reported. This encouraging data may aid surgical decision-making and patient selection for surgery.
Authors
- Peter Senior (ORCID: https://orcid.org/0000-0003-1033-8673)
- Andrew R. Pepper (ORCID: https://orcid.org/0000-0002-2227-4446)
- Zofia Czarnecka (ORCID: https://orcid.org/0000-0002-8788-7585)
- David L. Bigam (ORCID: https://orcid.org/0000-0003-2285-4173)
- Anna Lam (ORCID: https://orcid.org/0000-0003-3667-5205)
- Alice L. J. Carr (ORCID: https://orcid.org/0000-0003-0704-8843)
- Tatsuya Kin (ORCID: https://orcid.org/0000-0002-5179-6067)
- Khaled Dajani
- Blaire Anderson
- A.M. James Shapiro
- Kevin Verhoeff
- Robin Lucciantonio
Institutions
- University of Alberta (CA)
- Cégep Garneau (CA)
Publication Details
- Journal
- Annals of Surgery
- Published
- 2025-08-12
- DOI
- https://doi.org/10.1097/sla.0000000000006909
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00